VALERIE MILLER: Open Payments
NPI 1043860158 · CONVERSE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 31 payments from 10 companies in 2025. Trend: 2023 $945 · 2024 $1,270 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $189 |
| Abbott Laboratories | 2 | $171 |
| PFIZER INC. | 11 | $129 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| ABBVIE INC. | 2 | $52 |
| Amgen Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: FREESTYLE LIBRE 3, ZEPBOUND, NURTEC ODT, MOUNJARO, ELIQUIS, OTEZLA, UBRELVY, XIFAXAN.
Industry payments across TX — which companies pay providers there.
